Covered recipient · General Payments record
TIERRA J PAGE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$6,372.99
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $467.02 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $249.62 | 11 |
| Janssen Pharmaceuticals, Inc | $139.02 | 4 |
| Teva Pharmaceuticals USA, Inc. | $33.91 | 2 |
| Supernus Pharmaceuticals, Inc. | $26.33 | 1 |
| Indivior Inc. | $18.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.17 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778507 | CMS |
| ABBVIE INC. | $5.44 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778509 | CMS |
| ABBVIE INC. | $118.93 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778511 | CMS |
| ABBVIE INC. | $22.44 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778513 | CMS |
| ABBVIE INC. | $7.24 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778515 | CMS |
| ABBVIE INC. | $19.08 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778517 | CMS |
| ABBVIE INC. | $10.32 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778519 | CMS |
| ABBVIE INC. | $18.24 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778521 | CMS |
| ABBVIE INC. | $20.96 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778523 | CMS |
| ABBVIE INC. | $5.40 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778525 | CMS |
| ABBVIE INC. | $5.40 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107778527 | CMS |
| Indivior Inc. | $18.14 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144566666 | CMS |
| Janssen Pharmaceuticals, Inc | $1.70 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078139805 | CMS |
| Janssen Pharmaceuticals, Inc | $102.53 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078139407 | CMS |
| Janssen Pharmaceuticals, Inc | $16.31 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078140173 | CMS |
| Janssen Pharmaceuticals, Inc | $18.48 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078140245 | CMS |
| Supernus Pharmaceuticals, Inc. | $26.33 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147899668 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.50 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151507731 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.41 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151507822 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.